{"id":"NCT00514735","sponsor":"Medtronic Cardiac Rhythm and Heart Failure","briefTitle":"Tailored Treatment of Permanent Atrial Fibrillation","officialTitle":"Tailored Treatment of Permanent Atrial Fibrillation - TTOP-AF","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-05","primaryCompletion":"2010-11","completion":"2010-11","firstPosted":"2007-08-10","resultsPosted":"2012-05-09","lastUpdate":"2018-10-16"},"enrollment":210,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Atrial Fibrillation"],"interventions":[{"type":"PROCEDURE","name":"Medtronic Cardiac Ablation System","otherNames":[]},{"type":"DRUG","name":"Class I or III Antiarrhythmic Medications","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this trial is to evaluate the safety and efficacy of the Medtronic Cardiac Ablation System compared to medical therapy in the persistent and long-standing persistent atrial fibrillation population.","primaryOutcome":{"measure":"Chronic Effectiveness","timeFrame":"6 months","effectByArm":[{"arm":"Ablation Management","deltaMin":56,"sd":null},{"arm":"Medical Management","deltaMin":26,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":24,"countries":["United States","Netherlands"]},"refs":{"pmids":["11583910","16908781","16077418","12591754","16101625","16159816","16689850","7206163","15172273","16009793","15383047","15864238","12756153","15172410","16510747","15005218","12875749","12435183","14623799","10097231","16533249","15851264","15928285","9741520","15184286","16948740","16443526","16118239","16923426","15741228"],"seeAlso":["http://www.ablationfrontiers.com"]},"adverseEventsSummary":{"seriousAny":{"events":41,"n":138},"commonTop":["hematoma","chest pain","bradycardia"]}}